Site Management/Investigator Payments Featured Articles
-
Sites Are 3X Likely To Die In The First Year Than New Businesses
11/7/2025
Milken Institute Health Director of Research Andrew Friedson, Ph.D., reveals the stark truth of site survivability and discusses how factors like available population and local economic conditions factor into survival rates.
-
Sponsors Collect Too Much "Non-Essential" Data, Say Tufts And TransCelerate
11/6/2025
A collaboration between Tufts CSDD, Tufts School of Medicine, and TransCelereate BioPharma revealed just how much extra data sponsors are collecting — and why that's a problem.
-
Participant Recruitment In LMIC Clinical Trials
11/5/2025
Due to the high burden of infectious diseases in low- and middle-income countries (LMICs), there is greater urgency for vaccine trials. Participant recruitment entails significant work with communities.
-
Global Implications Of Zero Tariffs On Indian Pharma Exports To China
11/5/2025
Discover the worldwide impacts of China’s zero-tariff policy on Indian pharmaceutical drugs.
-
Behavior Modeling Can Help Sponsors Better Understand Sites And Patients
11/4/2025
Learn how behavioral modeling can identify patients at risk of dropout and sites that may need additional support, so you can build a more resilient research network.
-
Funding Diversity Where It Starts — At the Site
11/3/2025
After crossing paths with retired family physician and researcher Dr. Bryce Palchick at two conferences, I learned about ACRO’s new Diversity & Inclusion Site Resource Grants Program — an effort funding community sites like Bryce’s to make trial diversity more than a buzzword by supporting real, grassroots engagement.
-
Clinical Trials At A Crossroads
10/22/2025
At DPHARM 2025, McKinsey’s Gaurav Agrawal warned that while clinical science is accelerating, trial operations aren’t keeping pace. He outlined a vision for 2035 built on scaling AI, expanding site ecosystems, and bringing trials closer to everyday patient care.
-
We Need Communication Beyond The "Blah, Blah, Blah"
10/20/2025
Miscommunication can derail clinical trials and lengthen study timelines. Discover how to improve communication among sponsors, CROs, and sites, and thus run more effective clinical trials.
-
100% U.S. Drug Tariffs: Implications For Pharma And Outsourcing
10/17/2025
Research Manager Mathini Ilancheran explores the effects of U.S. drug tariffs on global supply chains, multinational pharma firms, and critical partners across drug development.
-
Oncology PI Shares Lessons Learned And Successes Working With Basic Scientists
10/9/2025
Ranee Mehra, MD, shares her successes and discusses how they shape her approach to future research, as well as details the importance of working closely with basic scientists.